Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FCRL4 pseudogene 1 (FCRL4P1) is a pseudogene found within the Fc receptor-like (FCRL) gene cluster, located between the FCRL3 and FCRL4 loci. Unlike its neighboring genes, FCRL4P1 does not encode a functional protein or receptor. It consists of five exons and shares transcriptional orientation with the functional FCRL genes but lacks evidence for any biological function or involvement in immune signaling. It has been alternatively referred to as FcRH4ψ and IFGPx in earlier literature[1]. The presence of FCRL4P1 is noted in genomic studies of the FCRL family, but it is not regarded as a therapeutic target, receptor, or molecular biomarker[1]. FCRL4P1 is a pseudogene, not a protein-coding gene or functional receptor[1]. There is no evidence for any protein product, biological activity, or therapeutic targeting. It is not studied in disease, has no known biomarkers or drug interactions, and does not participate in canonical immune functions. There is nothing inherently wrong with the spelling or naming (FCRL4P1), but requesting therapeutic target information is inappropriate for a pseudogene, making the entry is_incorrect: true for most structured drug discovery contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FCRL4 pseudogene 1 (FCRL4P1).